TrialClinical drug investigation2017

Pharmacokinetics, Pharmacodynamics, and Safety of Entospletinib, a Novel pSYK Inhibitor, Following Single and Multiple Oral Dosing in Healthy Volunteers.

Srini Ramanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.